Suppr超能文献

幽门螺杆菌引起的胃部感染。

Gastric infection by Helicobacter pylori.

作者信息

Sachs George, Scott David R, Wen Yi

机构信息

Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

出版信息

Curr Gastroenterol Rep. 2011 Dec;13(6):540-6. doi: 10.1007/s11894-011-0226-4.

Abstract

Helicobacter pylori infects half of the world's population and plays a causal role in ulcer disease and gastric cancer. This pathogenic neutralophile uniquely colonizes the acidic gastric milieu through the process of acid acclimation. Acid acclimation is the ability of the organism to maintain periplasmic pH near neutrality in an acidic environment to prevent a fall in cytoplasmic pH in order to maintain viability and growth in acid. Recently, due to an increase in antibiotic resistance, the rate of H. pylori eradication has fallen below 80% generating renewed interest in novel eradication regimens and targets. In this article, we review the gastric biology of H. pylori and acid acclimation, various detection procedures, antibiotic resistance and the role that gastric acidity plays in the susceptibility of the organism to antibiotics currently in use and propose several novel drug targets that would promote eradication in the absence of antibiotics.

摘要

幽门螺杆菌感染了全球一半的人口,并在溃疡病和胃癌中起致病作用。这种致病性嗜中性菌通过酸适应过程独特地定殖于酸性胃环境中。酸适应是指生物体在酸性环境中维持周质pH接近中性,以防止细胞质pH下降,从而在酸性环境中维持生存能力和生长的能力。最近,由于抗生素耐药性增加,幽门螺杆菌根除率已降至80%以下,这引发了人们对新型根除方案和靶点的新兴趣。在本文中,我们综述了幽门螺杆菌的胃生物学特性和酸适应、各种检测方法、抗生素耐药性以及胃酸在该生物体对目前使用的抗生素易感性中所起的作用,并提出了几种新的药物靶点,这些靶点将在无抗生素的情况下促进根除。

相似文献

1
Gastric infection by Helicobacter pylori.幽门螺杆菌引起的胃部感染。
Curr Gastroenterol Rep. 2011 Dec;13(6):540-6. doi: 10.1007/s11894-011-0226-4.
2
Gastric infection by Helicobacter pylori.幽门螺杆菌引起的胃部感染。
Curr Gastroenterol Rep. 2009 Dec;11(6):455-61. doi: 10.1007/s11894-009-0070-y.
3
The life and death of Helicobacter pylori.幽门螺杆菌的生死
Gut. 1998 Jul;43 Suppl 1(Suppl 1):S56-60. doi: 10.1136/gut.43.2008.s56.
6
The effectiveness of systemic eradication therapy against oral Helicobacter pylori.系统根除治疗对口腔幽门螺杆菌的有效性。
J Oral Pathol Med. 2011 May;40(5):428-32. doi: 10.1111/j.1600-0714.2010.00989.x. Epub 2010 Dec 28.
9
Pathogenesis and clinical management of gastric infection.胃感染的发病机制和临床管理。
World J Gastroenterol. 2019 Oct 7;25(37):5578-5589. doi: 10.3748/wjg.v25.i37.5578.
10
The gastric biology of Helicobacter pylori.幽门螺杆菌的胃部生物学
Annu Rev Physiol. 2003;65:349-69. doi: 10.1146/annurev.physiol.65.092101.142156. Epub 2002 May 1.

引用本文的文献

2
[Current Status and Future Perspectives of Tegoprazan-Based Eradication Therapy].[基于替戈拉赞的根除治疗的现状与未来展望]
Korean J Helicobacter Up Gastrointest Res. 2024 Jun;24(2):100-102. doi: 10.7704/kjhugr.2024.0023. Epub 2024 Jun 10.
3
[Vonoprazan-based Dual and Triple Therapy for Eradication].基于沃克帕唑的根除幽门螺杆菌的双重和三重疗法
Korean J Helicobacter Up Gastrointest Res. 2023 Sep;23(3):228-230. doi: 10.7704/kjhugr.2023.0022. Epub 2023 Sep 8.
7
Vonoprazan: A Review in Helicobacter pylori Infection.沃诺拉赞:治疗幽门螺杆菌感染的药物。
Drugs. 2024 Mar;84(3):319-327. doi: 10.1007/s40265-023-01991-5. Epub 2024 Feb 23.

本文引用的文献

5
Vaccinating against Helicobacter pylori infection.接种疫苗以预防幽门螺杆菌感染。
Nat Rev Gastroenterol Hepatol. 2011 Mar;8(3):133-40. doi: 10.1038/nrgastro.2011.1. Epub 2011 Feb 8.
8
Strategies for gastric cancer in the modern era.胃癌的现代治疗策略。
World J Gastrointest Oncol. 2010 Sep 15;2(9):335-41. doi: 10.4251/wjgo.v2.i9.335.
10
Helicobacter pylori and esophageal disease: wake-up call?幽门螺杆菌与食管疾病:警钟?
Gastroenterology. 2010 Dec;139(6):1819-22. doi: 10.1053/j.gastro.2010.10.037. Epub 2010 Oct 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验